Dr. Emma Guttman-Yassky
Claim this profileIcahn School of Medicine at Mount Sinai
Studies Burn Injury
Studies Alopecia Areata
5 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Emma Guttman-Yassky is currently running
Dupilumab
for Alopecia Areata
This is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will take place at 4 sites. This trial will enroll a total of 68 patients with moderate to severe AA (affecting more than 50% of the scalp) at the time of screening with a targeted 54 subjects completers through Week 48. AA subjects must have evidence of hair regrowth within the last 7 years of their last episode of hair loss; and have screening IgE ≥ 200 and/or have personal and/or familial history of atopy. Subjects will be randomized (2:1) to either receive weekly dupilumab or placebo for 48 weeks, with all subjects completing participation through Week 48 receiving an additional 48 weeks of dupilumab (through Week 96).
Recruiting0 awards Phase 27 criteria
GSK1070806
for Atopic Dermatitis
This study is parallel group, placebo-controlled dose-ranging study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of GSK1070806 in adult participants with moderate to severe Atopic Dermatitis (AtD), who have previously been treated with medicated topical treatments or a biologic therapy.
Recruiting0 awards Phase 210 criteria
More about Emma Guttman-Yassky
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Emma Guttman-Yassky has experience with
- Dupilumab
- Placebo
- Ritlecitinib
- Lebrikizumab
- GSK1070806
Breakdown of trials Emma Guttman-Yassky has run
Burn Injury
Alopecia Areata
Atopic Dermatitis
Vasculopathic Skin Disease
Scarring Alopecia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emma Guttman-Yassky specialize in?
Emma Guttman-Yassky focuses on Burn Injury and Alopecia Areata. In particular, much of their work with Burn Injury has involved treating patients, or patients who are undergoing treatment.
Is Emma Guttman-Yassky currently recruiting for clinical trials?
Yes, Emma Guttman-Yassky is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Emma Guttman-Yassky has studied deeply?
Yes, Emma Guttman-Yassky has studied treatments such as Dupilumab, Placebo, Ritlecitinib.
What is the best way to schedule an appointment with Emma Guttman-Yassky?
Apply for one of the trials that Emma Guttman-Yassky is conducting.
What is the office address of Emma Guttman-Yassky?
The office of Emma Guttman-Yassky is located at: Icahn School of Medicine at Mount Sinai, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount Sinai.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.